These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 15848577

  • 21. Donor-specific transfusions have long-term beneficial effects for human renal allografts.
    Flye MW, Burton K, Mohanakumar T, Brennan D, Keller C, Goss JA, Sicard GA, Anderson CB.
    Transplantation; 1995 Dec 27; 60(12):1395-401. PubMed ID: 8545863
    [Abstract] [Full Text] [Related]

  • 22. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression.
    Mikhalski D, Wissing KM, Ghisdal L, Broeders N, Touly M, Hoang AD, Loi P, Mboti F, Donckier V, Vereerstraeten P, Abramowicz D.
    Transplantation; 2008 Apr 15; 85(7 Suppl):S3-9. PubMed ID: 18401260
    [Abstract] [Full Text] [Related]

  • 23. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
    Kim HC, Hwang EA, Han SY, Park SB, Kim HT, Cho WH.
    Transplant Proc; 2004 Sep 15; 36(7):2082-3. PubMed ID: 15518753
    [Abstract] [Full Text] [Related]

  • 24. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Gallon LG, Winoto J, Chhabra D, Parker MA, Leventhal JR, Kaufman DB.
    Transplantation; 2007 May 27; 83(10):1324-9. PubMed ID: 17519781
    [Abstract] [Full Text] [Related]

  • 25. Usefulness of Tacrolimus without Basiliximab in Well-Matched Living-Donor Renal Transplant Recipients in Korea.
    Baek CH, Kim JH, Yu H, Shin E, Cho H, Kim H, Yang WS, Han DJ, Park SK.
    Exp Clin Transplant; 2016 Aug 27; 14(4):389-93. PubMed ID: 27228054
    [Abstract] [Full Text] [Related]

  • 26. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
    Cantarovich M, Durrbach A, Hiesse C, Ladouceur M, Benoit G, Charpentier B.
    Transplantation; 2008 Dec 27; 86(12):1732-7. PubMed ID: 19104413
    [Abstract] [Full Text] [Related]

  • 27. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A, Moreso FJ, Seron D, Gil-Vernet S, Cruzado JM, Castelao AM, Grinyó JM.
    Transplant Proc; 2004 Jun 27; 36(5):1305-7. PubMed ID: 15251318
    [Abstract] [Full Text] [Related]

  • 28. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B.
    Transplant Rev (Orlando); 2009 Jan 27; 23(1):47-52. PubMed ID: 19027616
    [Abstract] [Full Text] [Related]

  • 29. Clinical aspects of sensitization.
    Katznelson S, Bhaduri S, Cecka JM.
    Clin Transpl; 1997 Jan 27; ():285-96. PubMed ID: 9919412
    [Abstract] [Full Text] [Related]

  • 30. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
    Morales JM, Andrés A, Dominguez-Gil B, Arriola M, Gutiérrez MJ, Hernández E, Ortuño T, Praga M.
    Transplant Proc; 2005 Nov 27; 37(9):3738-42. PubMed ID: 16386523
    [Abstract] [Full Text] [Related]

  • 31. A 39-month follow-up study to evaluate the safety and efficacy in kidney transplant recipients treated with modified-release tacrolimus (FK506E)-based immunosuppression regimen.
    Han DJ, Park JB, Kim YS, Kim SJ, Ha J, Kim HC, Kim SJ, Moon IS, Yang CW.
    Transplant Proc; 2012 Jan 27; 44(1):115-7. PubMed ID: 22310592
    [Abstract] [Full Text] [Related]

  • 32. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A.
    Acta Med Port; 2004 Jan 27; 17(1):8-14. PubMed ID: 15636737
    [Abstract] [Full Text] [Related]

  • 33. Influence of tacrolimus plus mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients.
    Demirbaş A, Tuncer M, Yavuz A, Gürkan A, Kaçar S, Cetinkaya R, Tekin S, Akbaş SH, Akaydin M, Ersoy F, Yakupoğlu G.
    Transplant Proc; 2004 Jan 27; 36(1):175-7. PubMed ID: 15013338
    [Abstract] [Full Text] [Related]

  • 34. Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients.
    Gathogo E, Harber M, Bhagani S, Levy J, Jones R, Hilton R, Davies G, Post FA, UK HIV Kidney Transplantation Study Group.
    Transplantation; 2016 Apr 27; 100(4):871-8. PubMed ID: 26413990
    [Abstract] [Full Text] [Related]

  • 35. The impact of late acute rejection after cadaveric kidney transplantation.
    Joseph JT, Kingsmore DB, Junor BJ, Briggs JD, Mun Woo Y, Jaques BC, Hamilton DN, Jardine AG, Jindal RM.
    Clin Transplant; 2001 Aug 27; 15(4):221-7. PubMed ID: 11683814
    [Abstract] [Full Text] [Related]

  • 36. Rescue immunosuppressive therapies in living-related renal allotransplant: a long-term prospective randomized evaluation.
    Bakr MA, Gheith OA, Ismael AM, Baz ME, Shehab El-Dein AB, Ghoneim MA.
    Exp Clin Transplant; 2008 Mar 27; 6(1):48-53. PubMed ID: 18405245
    [Abstract] [Full Text] [Related]

  • 37. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Sobh M, Ghoneim M.
    Saudi J Kidney Dis Transpl; 2008 Jul 27; 19(4):564-70. PubMed ID: 18580014
    [Abstract] [Full Text] [Related]

  • 38. Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis.
    Siddiqi N, McBride MA, Hariharan S.
    Kidney Int; 2004 May 27; 65(5):1906-13. PubMed ID: 15086934
    [Abstract] [Full Text] [Related]

  • 39. Long-term results of spousal renal donor transplants with donor-specific blood transfusions.
    Miura S, Okazaki H, Sato T, Amada N, Ohashi Y, Sato K.
    Transplant Proc; 2001 May 27; 33(7-8):3417-9. PubMed ID: 11750463
    [No Abstract] [Full Text] [Related]

  • 40. Mizoribine in combination therapy with tacrolimus for living donor renal transplantation: analysis of a nationwide study in Japan.
    Akiyama T, Okazaki H, Takahashi K, Hasegawa A, Tanabe K, Uchida K, Takahara S, Toma H.
    Transplant Proc; 2005 Mar 27; 37(2):843-5. PubMed ID: 15848551
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.